No trial date has been set for Shire Ltd.’s patent infringement suits against Barr, Mylan, Inc., Mylan Pharmaceuticals, Inc., and Matrix Laboratories, Inc., and Natco Pharma Limited.
In February 2009, Shire…
Shire Ltd. is pursuing two suits against Nostrum Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent Nos. 5,912,013…
Shire Ltd.’s suit against CorePharma LLC for the alleged infringement of U.S. Patent Nos. 5,912,013, was settled on July 14, 2009.
The patent-at-issue covers an advanced drug delivery system using carbamazepine.
On…
No trial date has been set for the litigation between Shire Ltd. and Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos.…
Actavis Elizabeth LLC’s suit against the U.S. Food and Drug Administration remains stayed, according to Shire Ltd.’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission.
On Feb. 24,…